跳至主要内容
临床试验/NCT03598686
NCT03598686已完成不适用

Home-based Plus Self-testing to Improve HIV Testing Coverage in Rural Lesotho - a Cluster Randomized Controlled Trial in Rural Lesotho.

Tracy Glass2 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2018年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10,000
试验地点
2
主要终点
HIV testing coverage

研究概览

简要总结

This cluster-randomized trial aims to evaluate the efficacy of the use of oral HIV self-testing (HIVST) among individuals who are absent or who decline HIV testing during home-based HIV testing

详细描述

By launching the 90-90-90 strategy UNAIDS has shown a way forward in controlling and finally eradicating the deadly AIDS epidemic. Recent global data shows that progress towards the first UNAIDS target, i.e. to ensure that 90% of HIV-positive individuals are aware of their status, is lower than progress in other areas of the HIV care cascade. It is estimated that still approximately 2.7 million HIV-positive people do not know their HIV status.

Home- or community-based HIV testing has been proven to be very effective in resource-limited settings and therefore is a key strategy endorsed by WHO. Although acceptance of testing during such campaigns is usually very high, coverage remains low due to absent household members. And usually these absent people are men and young adults - both of which have a disproportionately high risk of HIV acquisition and poorer clinical outcomes once infected.

Oral HIV self-testing (HIVST) has shown to be an accurate diagnostic tool with a high acceptance and feasibility in sub-Saharan Africa. Experiences from the sub-Saharan region suggest that when HIV self-testing is provided as part of a home-based HIV testing campaigns, it can increase uptake of testing and facilitate linkage to care, especially among individuals who are at high risk of HIV infection.

The HOSENG study is linked to a follow-up trial, the VIBRA study. Together they are called the GET ON ("GETing tOwards Ninety") research project. The HOSENG study with its home-based HIV testing campaign provides the platform for the VIBRA study.

The HOSENG study is a cluster randomized, parallel-group (1:1:1:1 allocation), open-label, superiority, prospective clinical trial. Clusters are stratified by district, size of village, and village access to the nearest health facility.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

HIV testing coverage

时间窗: within 120 days after enrolment (i.e. HTS campaign)

HIV testing coverage among individuals aged 12 years or older in the surveyed area within 120 days after the HIV testing and service (HTS) campaign, defined as the proportion of all individuals 12 years or older living in a household of the surveyed area with a confirmed HIV test result

次要结局

  • HIV testing coverage among adolescents and young adults (ADORE nested study outcome)(within 120 days after enrolment (i.e. HTS campaign))
  • Blood-based HIV testing uptake(at enrolment (i.e. HTS campaign))
  • Overall HIV testing coverage(within 120 days after enrolment (i.e. HTS campaign))
  • Oral HIVST uptake using OraQuick(at enrolment (i.e. HTS campaign) and within 120 days after enrolment (i.e. HTS campaign))

研究者

发起方
Tracy Glass
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Tracy Glass

Head of Statistics, Principal Investigator

Swiss Tropical & Public Health Institute

研究点 (2)

Loading locations...

相似试验